Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Novavax

Pinterest

Pubmatic

Short-term pain in these innovators means long-term opportunity for investors.

Like Discounts? These 5 Game-Changing Stocks Are 35% (or More) Below Their 52-Week Highs

Michael Gorton's Recuro Health sees a bright future in home testing for blood sugar, heart health and more.

Teladoc Founder's Startup Brings Patient Monitoring Home

This stock looks like a great one to buy sooner rather than later.

3 Reasons to Buy Teladoc Health Stock in August

Teladoc's Earnings Had 1 Important Metric for Both Bulls and Bears

Root

Trupanion

Innovation and time could allow a sizable investment in this trio to turn into a life-altering amount of money.

3 Special Stocks That Can Turn $25,000 Into $1 Million in 25 Years (or Less)

Talkspace

They're making inroads on delivering behavioral health from afar.

2 Telehealth Companies Worth Adding to Your Watchlist

Heavy losses in its second-quarter earnings report contributed to the sell-off.

Why Teladoc Stock Fell 11% in July

Lufax Holding

Travelers

Picking stocks whose market capitalizations surpass $10 billion and whose price-book ratios are not above 1.5 could grant value investors a higher likelihood to unearth opportunities among U.S.-listed equities.

3 Low Price-Book Ratio Stock Picks

Exact Sciences

MercadoLibre

Roku

Shopify

Block

Tesla

Twilio

Zillow

Trimble

The haters have come out against portfolio manager Cathie Wood. In fact, an ETF is preparing to launch that bets against her stocks to buy.

10 Stocks to Buy From Cathie Wood's Fleet of ETFs

Ciena

CyberArk Software

Datadog

Electronic Arts

Fiverr

Constellation Brands

Investors should be more selective in uncertain times. These coronavirus stocks are fundamentally strong enough to rebound after another potential pullback.

7 Coronavirus Stocks to Buy as the Delta Variant Rises

Where Teladoc is headed is most important.

What Really Mattered in Teladoc Health's Q2 Results

PURCHASE, NY, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that David Sides, chief operating officer, and Mala Murthy, chief financial officer, will participate in the Canaccord Genuity Growth Conference on August 11, 2021, at 1:00 p.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.

Teladoc Health to Participate in Canaccord Genuity Growth Conference

The results weren't nearly as bad as last week's sell-off made them out to be.

Why I'm Not Worried About Teladoc's Q2 Earnings Miss

Pacific Biosciences of California

Trillium Therapeutics

These companies could upend the industry in the years ahead.

$5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years

Teladoc reported the results for its Q2 after the market closed on 7/27. The results were a modest beat in terms of revenue and revenue guidance was also increased modestly beyond the quarterly over-attainment.

Teladoc: Company Is Healthy, But Share Price Less So

Newell Brands

Uber

Microchip Technology

Magnolia Oil & Gas Corp

ResMed

Rapid7

United States Cellular

With the trading day nearly halfway over, the broad markets were edging higher, led by the Nasdaq's gain of about 0.5%.

Monday Afternoon Analyst Upgrades and Downgrades: Newell Brands, Teladoc Health, Uber and More

The telemedicine company is down significantly in recent months. What do its most recent results say about a potential comeback?

3 Key Takeaways From Teladoc's Q2 Earnings

Airbnb

Redfin

These innovative stocks can turn a healthy pile of cash into a life-altering amount of money.

5 Stocks That Can Turn $50,000 Into $1 Million by 2040

Microsoft

Veeva Systems

Teaming up is smart for Microsoft and Teladoc.

Could the Microsoft-Teladoc Partnership Threaten Veeva Systems?

The telemedicine leader's investments for growth are bearing fruit.

Worried About Teladoc's Post-Pandemic Future? This Statistic Suggests You Shouldn't Be

These tech companies are disrupting massive industries.

Got $20? Buy These Smart Growth Stocks Right Now

Doximity

Doximity went public last month, and it is already trading at a steep price tag.

Is This New Healthcare IPO Worth the Hype?

Slowing growth in the face of exploding competition for digital health services should have investors more than a little concerned.

Can Teladoc Health Stock Start Climbing Again?

The company had a better story than some investors initially thought.

3 Things You Might Have Missed With Teladoc's Q2 Update

Spotify

Cathie Wood-led Ark Investment Management on Wednesday piled up 713,842 shares, estimated to be worth about $108.37 million, in Teladoc Health Inc (NYSE:TDOC), a day after the telemedicine company reported a wider-than-expected quarterly loss. Teladoc shares opened 10.8% lower on Wednesday but pared losses in the second half to close 0.53% higher at $151.81.

News for Teladoc Stock (TDOC)